Table-III.
Group | LVEF (%) | LVEDD (mm) | LVESD (mm) | ||||||
---|---|---|---|---|---|---|---|---|---|
| |||||||||
T0 | T1 | T2 | T0 | T1 | T2 | T0 | T1 | T2 | |
Control group (n = 45) | 52.61±4.26 | 55.26±3.90a | 57.62±3.02ab | 52.24±1.52 | 50.25±1.13a | 46.90±3.85ab | 40.21±1.02 | 38.57±1.08a | 37.25±1.10ab |
Intervention group (n = 45) | 52.73±4.19 | 58.62±3.10a | 61.20±2.52ab | 52.39±1.46 | 48.25±2.82a | 43.25±3.62ab | 40.03±0.95 | 36.54±1.11a | 34.90±1.25ab |
t | 0.135 | 4.524 | 6.106 | 0.477 | 4.416 | 4.633 | 0.866 | 8.793 | 9.468 |
P | 0.893 | 0.000 | 0.000 | 0.634 | 0.000 | 0.000 | 0.389 | 0.000 | 0.000 |
| |||||||||
Group | MAP (mmHg) | LVWT (mm) | NT-proBNP (ng/L) | ||||||
| |||||||||
T0 | T1 | T2 | T0 | T1 | T2 | T0 | T1 | T2 | |
| |||||||||
Control group ( = 45) | 125.32±9.60 | 123.05±7.10a | 118.25±7.45ab | 13.06±0.95 | 10.25±0.92a | 9.52±0.90ab | 8.46±1.02 | 6.20±0.80a | 5.70±0.99ab |
Intervention group ( = 45) | 125.76±9.58 | 119.25±6.90a | 115.25±4.25ab | 13.20±0.92 | 9.85±0.80a | 8.16±0.74ab | 8.52±1.09 | 5.28±1.02a | 4.46±0.80ab |
t | 0.218 | 2.575 | 2.346 | 0.710 | 2.201 | 7.830 | 0.270 | 4.761 | 6.535 |
P | 0.828 | 0.012 | 0.021 | 0.479 | 0.030 | 0.000 | 0.788 | 0.000 | 0.000 |
Notes: Compared in the same group at T0,
p< 0.05; compared in the same group at T1, bp< 0.05.